Balram Bhargava: Latest News

All news where Balram Bhargava is mentioned

23.06.2022 / 17:44

Scan for possible COVID mutation: Health min Mandaviya as cases spike

Union Health Minister Mansukh Mandaviya, who chaired a high-level COVID review meeting on Thursday, directed state governments to focus on districts reporting high case positivity and undertake adequate testing with a higher proportion of RTPCR tests. The meeting was called owing to the sudden spike in COVID-19 cases. He further instructed the officials to continue to focus on surveillance and on Whole Genome Sequencing (WGS) to scan for any possible mutation along with increasing the pace of vaccination. The meeting was attended by the core team of experts including Dr Randip Guleria, ICMR Director-General Dr Balram Bhargava and NCDC director Sujeet Singh.

Balram Bhargava Union Health Rajesh Bhushan Mansukh Mandaviya India city Delhi testing Health reports

WHO report on excess Covid-19 deaths in India: What top health experts say

PTI report.

Niti Aayog Randeep Guleria Balram Bhargava India covid-19 death reports

Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI: Report

NEW DELHI :

Balram Bhargava city New Delhi India city Hyderabad city Pune covid-19 information vaccine

Mandaviya reviews public health preparedness for covid-19 case surge in China & other countries

NEW DELHI :

Randeep Guleria Balram Bhargava Rajesh Bhushan Mansukh Mandaviya China city New Delhi India Hong Kong covid-19 infection Health

India calls for aggressive genome sequencing as Covid cases spike in Asia, Europe

Covid-19 cases are spiking in some Asian and European countries again.

Tedros Adhanom Ghebreyesus Health Organisation Niti Aayog Randeep Guleria Balram Bhargava Rajesh Bhushan Rajesh Gokhale China Singapore India Hong Kong Vietnam covid-19 Government Health

'Don't give Molnupiravir to...': WHO updates guidelines on Merck's Covid drug. Read here

COVID-19 therapeutics to include a “conditional recommendation" on Merck & Co's Covid drug Molnupiravir, a new antiviral medicine. Under this conditional approval, Merck's Covid-19 antiviral pill was approved for patients who are in the early stages of the disease.WHO has updated its living guidelines on #COVID19 therapeutics to include a conditional recommendation on molnupiravir, a new antiviral medicine.https://t.co/ZRygSEAbzC

Balram Bhargava India covid-19 recommendations Merck Updates

Covid in India: 92% deaths due to unvaccinated people in 2022, says ICMR

92 per cent of deaths in India has occurred due to unvaccinated individuals. He also said that India is the second country in the world, which has its own vaccine tracker.

Balram Bhargava India death vaccine Health

Covid-19 update: India logs 10,273 fresh Covid-19 cases, 243 deaths in last 24 hours

#COVID19 cases, 20,439 recoveries, and 243 deaths in the last 24 hours.Active case: 1,11,472 (0.26%)Daily positivity rate: 1.00%Total recoveries: 4,22,90,921Death toll: 5,13,724 Total vaccination: 1,77,44,08,129 pic.twitter.com/Qtyuy9lm72

Satyendar Jain Arvind Kejriwal Anil Baijal Manish Sisodia Niti Aayog Randeep Guleria Balram Bhargava Kailash Gahlot India city Delhi covid-19 death vaccine

Omicron symptoms: Covid patients suffer from wide range of conditions, experts explain why

Read on to understand the list of ‘mild’ to ‘worrying’ signs, and why people are experiencing varied symptoms.

Balram Bhargava India county Centre symptoms patient Waves

Karnataka govt issues new norms to disposal of at-home Covid testing kits

testing kits used at home, said state health minister K Sudhakar on Friday.

K.Sudhakar Balram Bhargava India city Delhi testing guidelines Health

Third Covid wave: Why is India not seeing severe illness, deaths? ICMR chief explains

Covid-19 in the third wave due to the high vaccination coverage across the country, said the central government on Thursday.

Balram Bhargava India death vaccine Waves

Covid-19: ICMR to study efficacy of Covishield, Covaxin against Omicron

NEW DELHI :

Balram Bhargava city New Delhi India city Pune vaccine Health reports

Covid-19 vaccine booster shot not priority at the moment, says Centre

Covid-19 vaccine is not the central theme in scientific and public health discussion at the moment, said the central government on Thursday. Instead, the administration of the two doses remains the main priority.

Balram Bhargava India covid-19 vaccine Health

Covid: 20% of India’s eligible population fully vaccinated, 62% have received one dose, says Centre

vaccinated with both doses against Covid-19, said the central government on Thursday. In addition to this, 62% of the people have been administered at least one anti-Covid jab.

Balram Bhargava India vaccine Government travelers

Centre developing covid-19 vaccine tracker

NEW DELHI :

Balram Bhargava city New Delhi India covid-19 vaccine Government Health

Govt warns of re-imposing Covid restrictions as tourists flock to hill stations

pic.twitter.com/mChazDg7dJ

Balram Bhargava India city Delhi travelers Waves

Can pregnant women be vaccinated against Covid-19? Here's what govt says

coronavirus. Addressing a press meet, Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava said, "The Ministry of Health has given guidelines that the vaccine can be given to the pregnant woman."

Balram Bhargava India information vaccine Coronavirus

Govt says Covid-19 Delta Plus variant now found in 11 states. List here

Delta Plus variant of Covid-19 have been recorded across 11 states of India, adding that the maximum number of such cases were in Maharashtra.

Balram Bhargava India covid-19 Health

Youth getting slightly more affected in COVID second wave: ICMR

New Delhi: The second wave of the COVID-19 pandemic is impacting slightly more number of younger people as they might have begun going out and also because of some variants of SARs-COV-2 prevalent in the country, the ICMR chief said on Tuesday.In response to a question on whether younger population were getting more affected, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said the comparison of data during the first and the second wave of COVID-19 has shown that there is not much age difference. People above the age of 40 are more vulnerable for adverse outcomes."We have found that younger people are getting slightly more involved because suddenly they have gone out and there are variants also prevalent in the

Balram Bhargava city New Delhi India covid-19 Government Waves

Covid moving towards Eastern India as Bengal, Odisha see surge in daily cases, deaths: Govt

What was discussed in the meeting?Dr Balram Bhargava, Secretary (Health Research) and DG ICMR, Dr (Prof) Sunil Kumar, DGHS, Arti Ahuja, Additional Secretary (Health), Sujeet K Singh, Director, NCDC were present along with Principal Secretary (Health), Mission Director (NHM), and State Surveillance Officer of the concerned states.The Covid-19 wave has already travelled to the northern states and Delhi. It was was mainly concentrated in Uttar Pradesh, Gujarat, Chhattisgarh and Maharashtra.

Sunil Kumar Balram Bhargava India city Delhi covid-19 death Waves

ICMR DG lists out three main reasons of rapid Covid-19 spread in India

ICMR DG listed three main reasons for the higher transmissibility of Covid-19 - laxity, Covid inappropriate behaviour and and various unidentified mutation."We have had tremendous amount of laxity, Covid-19 inappropriate behaviour and various unidentified mutation, of them some are of concern —UK, Brazilian and South African variants, which have been demonstrated to have higher transmissibility," said Dr. Balram Bhargava.We have had tremendous amount of laxity, COVID19 inappropriate behaviour and various unidentified mutation, of them some are of concern —UK, Brazilian and South African variants, which have been demonstrated to have higher transmissibility: ICMR DG Dr.

Balram Bhargava India Britain South Africa Brazil covid-19

Two new variants of Covid-19 found in Maharashtra, Kerala samples

Also Read | Bitter home truths for migrant workersEchoing similar views, Dr Balram Bhargava, Director General of ICMR pointed: "There is no direct relation between the recent surge in COVID19 cases in Maharashtra and some other States with the mutant virus strains N440K and E484Q of coronavirus disease."The E484Q strain was earlier detected in four sequences in Maharashtra as early as March and July 2020. The N440K mutation has been reported on 13 different occasions between May and September 2020 in Telangana, Andhra Pradesh and Assam," Dr Bhargava said.India has already reported different mutants of the Covid-19 virus.

Balram Bhargava India Britain South Africa Brazil virus covid-19 strain

Clinical trials indicate India's vaccines will be effective against Covid-19 variants: ICMR

THIRUVANANTHAPURAM : Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava has said interim results of the ongoing clinical trials indicated that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil.A paper on Covaxin's neutralisation potential against the UK strain has been accepted for publication, he said here on Thursday while addressing an international webinar "Kerala Health: Making the SDG A Reality,"organised by the Department of Health and Family Welfare, Government of Kerala.Also Read | Turnout modest for second covid shotIn the case of the variants from South Africa and Brazil, efforts were on to isolate the mutated

Balram Bhargava India Britain South Africa Brazil virus covid-19 vaccine

Interim data suggests India's Covid-19 vaccines effective against new variants, says ICMR

Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil, said the Indian Council of Medical Research (ICMR) on Thursday."The interim analysis report should be out in a week," said ICMR director-general Dr Balram Bhargava while addressing an international webinar "Kerala Health: Making the SDG A Reality," organised by the Department of Health and Family Welfare, Government of Kerala.Also Read | Turnout modest for second covid shotBhargava said that the third clinical trial of Covaxin BB152 had been completed as all the 25,800 volunteers involved in the exercise had been administered both doses.He also stated that a paper on Covaxin's neutralisation potential against the

Balram Bhargava India Britain South Africa Brazil virus covid-19 strain

About 21.5% Indians have Covid, majority still vulnerable to infection: Sero-survey

covid-19 in Indian Council of Medical Research’s (ICMR) third national seroprevalence survey. The survey also showed that large proportion of the population still remains vulnerable.Dr Balram Bhargava, Director General of ICMR who released findings of the survey on Thursday said that the prevalence of infection was found amongst 25.7% of healthcare workers.

Balram Bhargava India covid-19 infection

Bharat Biotech, SII approach DCGI for using COVID vaccine on those using blood thinners: ICMR DG

NEW DELHI : ICMR chief Balram Bhargava on Thursday said COVID-19 vaccine manufacturers--Bharat Biotech and Serum Institute--have approached the country’s drugs regulator to make changes in the fact sheet to permit the use of the vaccine on people using blood thinners.Responding to a query during a press conference, he clarified that there is no contraindication in administering COVID-19 vaccines to those who are on blood thinners such as aspirin and clopidogrel.The relative contraindication regarding blood thinners is mentioned in the fact sheet of both the vaccines, Covaxin and Covishield, he said."Both the companies have written to the DCGI regarding changing this point and that will happen very soon," Bhargava said.Oxford COVID-19

Balram Bhargava city New Delhi covid-19 vaccine patient

Bharat Biotech's Covaxin may have some advantages over other vaccines: ICMR chief on new Covid strain

Bharat Biotech's Covaxin may have some advantages over other vaccines on its effect over the new variant of coronavirus recently discovered in the UK.Dr Balram Bhargava's statement came on the day the Drugs Controller General of India (DCGI) approved the Oxford coronavirus vaccine and Bharat Biotech's Covaxin for immediate use."NIV scientists have successfully isolated the new virus strain and this will be tested against different vaccines. We hope potentially Bharat Biotech vaccine will have some advantages over other vaccines on this new strain," said Bhargava as the country has detected 29 patients of the new variant."New virus variant which is now more than 60% infective and creating havoc in the UK is worrisome.

Balram Bhargava India Britain virus vaccine strain Coronavirus

Non-judicious use of therapies may lead to mutation in coronavirus: ICMR

coronavirus, which in turn causes mutations in it, said ICMR director general Balram Bhargava.“We have to maintain the judicious use of therapies, which are going to benefit. If the benefit is not established, we should not use those therapies.

Balram Bhargava virus vaccine Coronavirus

New coronavirus strain: No need to change existing treatment protocol, says NTF

Covid-19 convened by ICMR on Saturday concluded that there is no need to change the existing treatment protocol in view of mutations emerging in the coronavirus strain.The meeting was held to discuss evidence-based modifications in testing, treatment and surveillance strategies after new variants of coronavirus was recently discovered in the UK and Nigeria.Convened under co-chairpersonship of professor Vinod Paul, a member Niti Aayog, and professor Balram Bhargava, the secretary at the Department of Health Research & Director General ICMR.

Niti Aayog Randeep Guleria Vinod Paul Balram Bhargava India Britain Nigeria covid-19 Coronavirus

ICMR chief Balram Bhargava undergoing treatment for Covid at AIIMS Trauma Centre

New Delhi: Indian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for COVID-19 at the AIIMS Trauma Centre here, official sources said on Friday.Bhargava, who is also a cardiologist, had tested positive for coronavirus infection around 7-8 days ago and was under home isolation, they said.He was admitted to the AIIMS Trauma Centre, which was converted into a dedicated COVID-19 facility on December 15.According to the sources, he is recovering well and likely to be discharged soon.This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.Click here to read the Mint ePaperMint is now on Telegram.

Balram Bhargava city New Delhi India county Centre covid-19 testing Coronavirus

Masks here to stay even after coronavirus vaccine is available, says ICMR chief

coronavirus pandemic, several health protocols have been put in place, which will stay for a long time and people will have to keep wearing masks even after a Covid-19 vaccine is available, Indian Council of Medical Research (ICMR) chief professor Balram Bhargava said on Saturday.The ICMR chief who was speaking at a webinar hosted by Lucknow's King George's Medical University (KGMU) has said that the country is making a rapid progress as far as the development of a coronavirus vaccine is concerned."We have a target to provide vaccine to 30 crore people by July next year. The future course of action will be decided after that.

Balram Bhargava India county King George covid-19 vaccine mask Coronavirus

Third wave of Covid-19 cases in Delhi due to air pollution, cold weather: ICMR

New Delhi: A third spik of covid-19 has come now in Delhi after the first two spikes in June and September, which is showing more cases than before, chief of Indian Council of Medical Research (ICMR) Dr Balram Bhargava said on Tuesday. Factors such as pollution, cold weather, festivals, wedding season, apart from travels in Delhi- NCR are leading to gatherings which are triggering a surge in cases, he said.At least 38,073 fresh covid-19 cases were reported in last 24 hours and 54% of new cases have been reported in 6 States and UTs with Delhi reporting the highest of 5,023 new cases, followed by West Bengal reporting 3907 new cases and then Kerala reporting 3593 new cases.

Balram Bhargava city New Delhi India city Delhi covid-19 death vaccine

ICMR may remove plasma therapy from Covid-19 treatment guidelines

New Delhi: The government is planning to delete convalescent plasma therapy from the national guidelines for covid-19 treatment after the Indian Council of Medical Research’s clinical trial showed that the therapy did not significantly benefit patients suffering from the disease, ICMR DG Balram Bhargava said on Tuesday.“The largest trial on plasma therapy has been done in India. We have had discussions at the National Task Force and we are discussing further with the joint monitoring group.

Balram Bhargava city New Delhi India covid-19 guidelines SOLIDARITY patient

COVID-19: Lockdown was effective, didn't have a huge peak in India, says ICMR DG

COVID-19 spread in the country, Indian Council of Medical Research (ICMR) director general Balram Bhargava on Tuesday said, "We distributed the COVID-19 curve in a way that we didn't have many deaths. It was because we had an effective lockdown.

Balram Bhargava Usa India covid-19 patient Coronavirus

Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India

New Delhi: Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started on Tuesday, with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune.“Today, we have screened some patients.

Balram Bhargava city New Delhi India city Pune city Oxford hospital covid-19 vaccine patient

ICMR aiding Serum Institute of India in clinical trials for 2 covid vaccines

covid-19 vaccine candidates developed by the University of Oxford and US-based company Novavax.The apex biomedical research agency is also helping Zydus Cadila conduct lab tests to detect antibody response, shows documents reviewed by Mint.

Balram Bhargava Usa India city Oxford covid-19 testing vaccine Government

COVID-19 vaccine in India sooner than expected? 'Emergency authorisation can be considered'

PTI.Indian Council of Medical Research (ICMR) Director General Balram Bhargava informed members of the parliamentary standing committee on home affairs that the vaccine candidates developed by Bharat Biotech, Cadila and the Serum Institute of India are at different stages of trial, said an MP present in the meeting, PTI reported. When asked about when will we have a COVID-19 vaccine, the MP said, Bhargava replied that normally the final trial takes about six to nine months but if the governments decides, an emergency authorisation could be considered, according news agency PTI.The COVID-19 vaccine candidates coordinated by Bharat Biotech and Zydus Cadila are nearing completion of phase II trials.

Balram Bhargava India hospital covid-19 vaccine Government

Covid-19 vaccine update: 3 Indian vaccines in different phases of clinical trial

coronavirus, India has three vaccine candidates which are in different phases of the clinical study, top ICMR scientist (Prof) Balram Bhargava informed on Tuesday. "So at the present moment, we have three Indian vaccine candidates which are in different phases of a clinical study.

Balram Bhargava India covid-19 information vaccine Coronavirus

Bharat Biotech, Zydus Cadila complete phase I of Covid-19 vaccine trials in just 3 weeks

New Delhi: Bharat Biotech International Ltd and Zydus Cadila Ltd have completed the phase I of clinical trials for their respective vaccine candidates against covid-19, just three weeks after the two companies started human dosing of the immunisation shots against the fatal respiratory disease, Indian Council of Medical Research director general Balram Bhargava said.“At the present moment, we have three vaccines in different levels of clinical testing. The first one is the inactivated virus vaccine, which is the Bharat Biotech vaccine, which has completed its Phase I study in 11 sites, and has started its phase II study...

Balram Bhargava city New Delhi India virus covid-19 testing vaccine

Russia has successfully fast tracked Covid-19 vaccine development, says India

Covid-19 vaccine development, which is purportedly deemed as the world's first coronavirus vaccine to launch as early as mid-August, Indian government today acknowledged Russia's success in its early phases of developing a vaccine.The Indian Medical Research Institute (ICMR)'s director general Balram Bhargava today said, "Russia has fast tracked a vaccine which has been successful in its early phases. They have fast tracked its development."Speaking at the press briefing, Balram also mentioned the success of China in speeding up the process of its Covid-19 vaccine programme and studies with that vaccine in the country.

Balram Bhargava China India Russia covid-19 vaccine Coronavirus

Capacity utilisation of pvt labs in testing Covid-19 is sub-optimal: Centre to states

New Delhi: The capacity utilisation of Covid-19 testing laboratories, particularly in the private sector, has been grossly sub-optimal in some states and union territories, the Centre pointed out on Wednesday.Aimed at removing all impediments in testing of Covid-19, Preeti Sudan, Health Secretary and Dr Balram Bhargava, director general, Indian Council of Medical (ICMR) on Wednesday urged the States/UTs to take immediate steps to facilitate and ramp up testing stating that ‘test-track-treat’ is the key strategy for early detection and containment of the pandemic.“States/UTs have been strongly advised to take all possible steps to ensure full capacity utilization of all Covid-19 testing laboratories in the States/UTs," said the union health

Preeti Sudan Balram Bhargava city New Delhi India Sudan covid-19 testing guidelines

No mathematical model correctly predicted future course of Covid-19 so far: ICMR chief

New Delhi: None of the mathematical models have correctly predicted the future course of coronavirus spread till now, the Indian Council of Medical Research (ICMR) chief said on Sunday.Dr Balram Bhargava, Director General, ICMR in an interview with Mint said that the modelling cannot incorporate all the factors responsible for disease spread.

Balram Bhargava city New Delhi India covid-19 testing Government

Delhi LG forms high-level panel, which includes ICMR DG, to tackle Covid-19 in national capital

New Delhi: Delhi Lt Governor Anil Baijal on Friday constituted a high-level committee, which includes Indian Council of Medical Research Director-General Balram Bhargava, to suggest effective steps to deal with COVID-19 outbreak in the national capital, sources said.Baijal is the chairman of Delhi Disaster Management Authority (DDMA).The six-member panel also includes two members of the National Disaster Management Authority (NDMA) and AIIMS Director Randeep Guleria, they said.The move came two days after Chief Minister Arvind Kejriwal met Union Home Minister Amit Shah and both the leaders discussed the COVID-19 situation in Delhi.With 34,867 COVID-19 cases so far, Delhi is in dire straits with the city recording 1,877 cases on Thursday,

Arvind Kejriwal Amit Shah Anil Baijal Randeep Guleria Lt Delhi Balram Bhargava city New Delhi India city Delhi covid-19 outbreak Government

India is not in community transmission stage: ICMR

New Delhi: While India’s total tally of covid-19 cases on Thursday reached 295,898 with 10,407 new cases, government maintained that the country is still not witnessing community transmission of the virus.India also recorded the highest single deaths on Thursday with 379 persons succumbing to the coronavirus.“India is not in community transmission; we have to continue with our strategy of testing, tracing, tracking, quarantine and containment measures; we should not give up our guard on these," said Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR).“India's mortality per lakh population is amongst the lowest in the world.

Balram Bhargava city New Delhi India covid-19 testing Ventilators

Covid-19: India not in community transmission stage, says ICMR amid rising cases

novel coronavirus outbreak and the daily spikes in the Covid-19 count, the government today said that India is "not in a community transmission" so far.Speaking at the Union Health Ministry pres conference today, Indian Council of Medical Research DG, Prof (Dr.) Balram Bhargava said, "India is such a large country and prevalence is very low.

Balram Bhargava India covid-19 outbreak Coronavirus

Senior ICMR scientist tests positive for coronavirus, met DG last week

The scientist, who is from Mumbai, had come to Delhi few days ago and tested positive for the virus on Sunday morning.

Balram Bhargava city New Delhi India city Mumbai city Delhi virus testing Coronavirus

NEW DELHI : The Indian Council of Medical Research has removed the price cap of ₹4,500 for the real-time polymerase chain reaction (RT-PCR) test used to detect COVID-19, asking states and UTs to negotiate with private labs to fix "mutually agreeable" rates for the test. In a letter to the state chief secretaries on Monday, ICMR Director General (D-G) Dr Balram Bhargava said the COVID-19 diagnostic supplies are stabilising because of the indigenous production of the kits.

Balram Bhargava city New Delhi India covid-19 testing pandemic Government

Covid-19: Over 1.1 lakh samples being tested every day at 612 labs, says ICMR

Amid the novel coronavirus outbreak in the country, which has led to more than 1. lakh Indians infected so far, the Indian Council of Medical Research today said that the over 1.1 lakh samples of Covid-19 testing are now being conducted every day at 612 laboratories.

Balram Bhargava India city Pune covid-19 death testing

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0